Cargando…
The Role of Native T1 and T2 Mapping Times in Identifying PD-L1 Expression and the Histological Subtype of NSCLCs
SIMPLE SUMMARY: T1 and T2 mapping are MRI techniques that are routinely used in the evaluation of both benign and malignant lesions in different organs and tissues. Immunohistochemical analysis is the gold standard method to assess the programmed death-ligand 1 protein (PD-L1) expression status in p...
Autores principales: | Bortolotto, Chandra, Messana, Gaia, Lo Tito, Antonio, Stella, Giulia Maria, Pinto, Alessandra, Podrecca, Chiara, Bellazzi, Riccardo, Gerbasi, Alessia, Agustoni, Francesco, Han, Fei, Nickel, Marcel Dominik, Zacà, Domenico, Filippi, Andrea Riccardo, Bottinelli, Olivia Maria, Preda, Lorenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296658/ https://www.ncbi.nlm.nih.gov/pubmed/37370861 http://dx.doi.org/10.3390/cancers15123252 |
Ejemplares similares
-
Correlation between PD-L1 Expression of Non-Small Cell Lung Cancer and Data from IVIM-DWI Acquired during Magnetic Resonance of the Thorax: Preliminary Results
por: Bortolotto, Chandra, et al.
Publicado: (2022) -
A comparative analysis of the effects of containment policies on the epidemiological manifestation of the COVID-19 pandemic across nine European countries
por: Podrecca, Chiara, et al.
Publicado: (2023) -
Oncogenic miR-9 is a target of erlotinib in NSCLCs
por: Chen, Xi, et al.
Publicado: (2015) -
PFKFB3 Inhibition Impairs Erlotinib-Induced Autophagy in NSCLCs
por: Lypova, Nadiia, et al.
Publicado: (2021) -
BRCA1 and STMN1 as prognostic markers in NSCLCs who received cisplatin-based adjuvant chemotherapy
por: Wang, Mingxing, et al.
Publicado: (2017)